Biotheranostics portal login
WebDetails. Developer of commercial-stage molecular diagnostics intended to guide cancer treatment. The company develops and commerc. Laboratory Services (Healthcare) San Diego, CA. 131 As of 2024. 000.00. 0000 0000-00-00. 000000&0 000.00. WebTesting may be ordered through NeoGenomics via our online test order system or by using the current NGS Solid Tumor Pathology Requisition. Storage & Transportation Use cold pack for transport. Make sure cold pack is not in direct contact with specimen. CPT Code (s)* 81540 for CancerTYPE ID.
Biotheranostics portal login
Did you know?
WebProvider Portal Patient Payment Portal Biotheranostics was acquired by Hologic in February 2024, and continues to offer its portfolio of proprietary genomic assays to … Biotheranostics, Inc. (BTX) complies with applicable Federal civil rights laws and … WebJan 6, 2024 · Published. Jan 6, 2024 1:28AM EST. M edical technology company Hologic Inc. has announced the acquisition of privately-held Biotheranostics Inc. in a deal worth $230 million. Shares of Hologic ...
WebFeb 22, 2024 · Biotheranostics also developed and markets the CancerTYPE ID test, which provides a molecular diagnosis for patients with uncertain or unknown cancers. In advanced cancer that has metastasized, it ... WebProvider Portal Patient Payment Portal Biotheranostics was acquired by Hologic in February 2024, and continues to offer its portfolio of proprietary genomic assays to …
Web1 day ago · My Account Login; Explore ... the consensus SV calls were downloaded from the ICGC data portal ... His spouse is an employee of Biotheranostics, Inc. L.B.A. is an inventor of US patent 10,776,718 ... WebBiotheranostics is a commercial-stage molecular diagnostics company that support physicians in the treatment of cancer patients. Acquired by Hologic San Diego, California, United States 11-50 Venture - Series Unknown Private www.biotheranostics.com/ 48,677 Highlights Total Funding Amount $32M Contacts 88 Employee Profiles 1 Investors 3
WebBeing part of Hologic only helps bring that hope closer to reality. In addition, patients facing the challenges of metastatic cancer will have broader access to our CancerTYPE ID offering that can aid in the diagnosis of the tumor type and subtypes representing 95% of all solid tumors.”. Both of Biotheranostics’ tests are PCR (polymerase ...
WebJan 5, 2024 · BioTheranostics's latest funding round was a Acquired for on January 5, 2024. BioTheranostics's valuation in January 2016 was $94.01M. BioTheranostics's latest post-money valuation is from January 2024. Sign up for a free trial to see BioTheranostics's valuations in January 2024 and more. downplayed antonymsWebFeb 22, 2024 · MARLBOROUGH, Mass.-- (BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, has completed its previously announced acquisition of molecular oncology leader Biotheranostics, Inc. … clays top dogWebMar 15, 2007 · Biotheranostics, Inc. is a provider established in San Diego, California operating as a Clinical Medical Laboratory. The NPI number of this provider is 1043344435 and was assigned on March 2007. The practitioner's primary taxonomy code is 291U00000X with license number CLIA 05D1065725 (CA). clay storage boxWebFor Breast Cancer Index Intended Use and Limitations, visit the full site. Biotheranostics, Inc., A Hologic Company. 6333 Sequence Dr., San Diego, CA 92121. 1 (877) 886-6739. downplayed meaning in hindiWebIn a clinical study of 547 patients considered to be clinically low risk (T1N0), Breast Cancer Index identified ~25% as likely to benefit from extended endocrine therapy and high risk … downplay defWebJun 29, 2024 · The Breast Cancer Index test, made by Biotheranostics, analyzes the activity of 11 genes to help predict the risk of early-stage, hormone-receptor-positive … clay storage heatersWebSign-in for online ordering (iStore), product documentation library, or online medical education and training. downplayed define